Crinetics Pharmaceuticals
CRNX
CRNX
226 hedge funds and large institutions have $3.42B invested in Crinetics Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 90 increasing their positions, 73 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 55
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
74% less call options, than puts
Call options by funds: $1.4M | Put options by funds: $5.45M
Holders
226
Holding in Top 10
9
Calls
$1.4M
Puts
$5.45M
Top Buyers
| 1 | +$171M | |
| 2 | +$50.3M | |
| 3 | +$21.8M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$17.8M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$16.4M |
Top Sellers
| 1 | -$67.4M | |
| 2 | -$37M | |
| 3 | -$31.1M | |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$23.2M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$21.1M |